| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7008624 |
Antagonists of interleukin-15 |
Mar. 7, 2006 |
| 7008625 |
Recombinant constructs of Borrelia burgdorferi |
Mar. 7, 2006 |
| 7008772 |
Compounds for immunodiagnosis of prostate cancer and methods for their use |
Mar. 7, 2006 |
| 7008779 |
PHELIX: a testis-specific protein expressed in cancer |
Mar. 7, 2006 |
| 7008790 |
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
Mar. 7, 2006 |
| 7005129 |
Non-toxic mutants of pathogenic gram-negative bacteria |
Feb. 28, 2006 |
| 7005270 |
Compositions and methods for detecting Treponema pallidum |
Feb. 28, 2006 |
| 7001600 |
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
Feb. 21, 2006 |
| 7001744 |
Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection |
Feb. 21, 2006 |
| 7001756 |
Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
Feb. 21, 2006 |
| 7001757 |
Protein |
Feb. 21, 2006 |
| 7002002 |
Abundant extracellular products and methods for their production and use |
Feb. 21, 2006 |
| 6998126 |
Selection of poultry Eimeria strains through extra-intestinal sporozoites |
Feb. 14, 2006 |
| 6994851 |
Method of inducing a CTL response |
Feb. 7, 2006 |
| 6994858 |
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
Feb. 7, 2006 |
| 6994861 |
Attenuated live neospora vaccine |
Feb. 7, 2006 |
| 6994870 |
Local nasal immunotherapy with allergen strip for allergic rhinitis |
Feb. 7, 2006 |
| 6995240 |
Treatment of inflammatory disease |
Feb. 7, 2006 |
| 6991792 |
Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase |
Jan. 31, 2006 |
| 6991793 |
Method of protecting fish against columnaris disease with modified live Flavobacterium columnare |
Jan. 31, 2006 |
| 6991794 |
Progenitor cell preservation factors and methods for and products of their use |
Jan. 31, 2006 |
| 6991797 |
M. tuberculosis antigens |
Jan. 31, 2006 |
| 6984381 |
Vaccine for the prevention of bacterial infection of the bovine mammary gland |
Jan. 10, 2006 |
| 6984384 |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
Jan. 10, 2006 |
| 6984625 |
Methods and compositions for modulating autoimmunity |
Jan. 10, 2006 |
| 6982085 |
TB diagnostic based on antigens from M. tuberculosis |
Jan. 3, 2006 |
| 6982088 |
Vaccine composition and stabilization method using high molecular weight PVP |
Jan. 3, 2006 |
| 6982316 |
Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
Jan. 3, 2006 |
| 6979447 |
Immunomodulation and effect on cell processes relating to serotonin family receptors |
Dec. 27, 2005 |
| 6979451 |
Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use |
Dec. 27, 2005 |
| 6977074 |
Method of inducing a CTL response |
Dec. 20, 2005 |
| 6977078 |
Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
Dec. 20, 2005 |
| 6974573 |
Antibody production in farm animals |
Dec. 13, 2005 |
| 6974579 |
Methods for treating vascular disorders |
Dec. 13, 2005 |
| 6974581 |
Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease |
Dec. 13, 2005 |
| 6972177 |
Method for the detection of prion diseases |
Dec. 6, 2005 |
| 6969520 |
Active immunization against clostridium difficile disease |
Nov. 29, 2005 |
| 6969602 |
Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas |
Nov. 29, 2005 |
| 6964766 |
Peptides for use in immunotherapy of autoimmune diseases |
Nov. 15, 2005 |
| 6964767 |
POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM |
Nov. 15, 2005 |
| 6964770 |
Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
Nov. 15, 2005 |
| 6964855 |
Peptides for detection to Anaplasma phagocytophilum |
Nov. 15, 2005 |
| 6962704 |
CHIMERIC GENE FORMED BY THE DNA SEQUENCES THAT ENCODE THE ANTIGENIC DETERMINANTS OF FOUR PROTEINS OF L. INFANTUM AND PROTEIN ENCODED BY SAID GENE, AND PHARMACEUTICAL COMPOSITION USEFUL FOR PRE |
Nov. 8, 2005 |
| 6962705 |
Hybrid Bacillus thuringiensis .delta.-endotoxins with novel broad-spectrum insecticidal activity |
Nov. 8, 2005 |
| 6962706 |
Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
Nov. 8, 2005 |
| 6962709 |
Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
Nov. 8, 2005 |
| 6962787 |
Diagnostic method for a transmissible spongiform encephalopathy or a prion disease |
Nov. 8, 2005 |
| 6960652 |
Compositions and methods for modifying toxic effects of proteinaceous compounds |
Nov. 1, 2005 |
| 6958158 |
Immune modulation device for use in animals |
Oct. 25, 2005 |
| 6958361 |
Compositions and methods for the therapy and diagnosis of breast cancer |
Oct. 25, 2005 |
|
|
|
